In February, 2021, Lisa was named Executive Director, Commercial Assessment, Insights & Analytics at Organon, a spin-off from Merck focused on women’s health and biosimilars businesses.
Previously, Lisa led the Global Customer Insights team at Merck & Co, Inc., USA, responsible for leveraging insights, analytics, and design to create innovative, compliant solutions to the challenges facing patients, providers, and payers in the delivery of healthcare.
A strategic, solutions-oriented business leader with more than 20 years of success delivering customer insights and experiences that drive business results, Lisa has been called a “change agent”, an “innovative disrupter”, and a “creator”, among others, for her efforts to challenge the status quo, harnessing the power of data, technology, behavioral science and emerging capabilities in the service of creating deeper insights and better solutions.
Member of Board of Directors
2021 Executive Committee
2020 Executive Committee
2019 Executive Committee
2018 Executive Committee
2017 Directors At Large